Caxton Associates LP
- SEC CIK
- 0000872573
- Latest filing
- Feb 14, 2025
ALLO holding history
Allogene Therapeutics, Inc. in every 13F filed by Caxton Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALLO overviewAll 13F holders of ALLOFull Q4 2024 holdings
- Shares (Q4 2024)
- 206,380
- Value
- $439.6K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 206,380 | $439.6K | <0.1% | −35,722−14.8% | Reduced | Holders |
| Q3 2024 | 242,102 | $677.9K | <0.1% | −224,008−48.1% | Reduced | Holders |
| Q2 2024 | 466,110 | $1.09M | <0.1% | +34,924+8.1% | Added | Holders |
| Q1 2024 | 431,186 | $1.93M | 0.1% | −343,907−44.4% | Reduced | Holders |
| Q4 2023 | 775,093 | $2.49M | 0.1% | +294,989+61.4% | Added | Holders |
| Q3 2023 | 480,104 | $1.52M | 0.2% | +410,520+590.0% | Added | Holders |
| Q2 2023 | 69,584 | $345.8K | 0.1% | +47,756+218.8% | Added | Holders |
| Q1 2023 | 21,828 | $107.8K | <0.1% | +21,828 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −41,645−100.0% | Sold out | Holders |
| Q1 2022 | 41,645 | $379.0K | <0.1% | +41,645 | New | Holders |